Literature DB >> 17434667

Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes.

Jon N Marsh1, Kathryn C Partlow, Dana R Abendschein, Michael J Scott, Gregory M Lanza, Samuel A Wickline.   

Abstract

Targeted, liquid perfluorocarbon nanoparticles are effective agents for acoustic contrast enhancement of abundant cellular epitopes (e.g., fibrin in thrombi) and for lower prevalence binding sites, such as integrins associated with tumor neovasculature. In this study, we sought to delineate the quantitative relationship between the extent of contrast enhancement of targeted surfaces and the density (and concentration) of bound perfluorocarbon (PFC) nanoparticles. Two dramatically different substrates were utilized for targeting. In one set of experiments, the surfaces of smooth, flat, avidin-coated agar disks were exposed to biotinylated nanoparticles to yield a thin layer of targeted contrast. For the second set of measurements, we targeted PFC nanoparticles applied in thicker layers to cultured smooth muscle cells expressing the transmembrane glycoprotein "tissue factor" at the cell surface. An acoustic microscope was used to characterize reflectivity for all samples as a function of bound PFC (determined via gas chromatography). We utilized a formulation of low-scattering nanoparticles having oil-based cores to compete against high-scattering PFC nanoparticles for binding, to elucidate the dependence of contrast enhancement on PFC concentration. The relationship between reflectivity enhancement and bound PFC content varied in a curvilinear fashion and exhibited an apparent asymptote (approximately 16 dB and 9 dB enhancement for agar and cell samples, respectively) at the maximum concentrations (approximately 150 microg and approximately 1000 microg PFOB for agar and cell samples, respectively). Samples targeted with only oil-based nanoparticles exhibited mean backscatter values that were nearly identical to untreated samples (<1 dB difference), confirming the oil particles' low-scattering behavior. The results of this study indicate that substantial contrast enhancement with liquid perfluorocarbon nanoparticles can be realized even in cases of partial surface coverage (as might be encountered when targeting sparsely populated epitopes) or when targeting surfaces with locally irregular topography. Furthermore, it may be possible to assess the quantity of bound cellular epitopes through acoustic means.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434667      PMCID: PMC1978071          DOI: 10.1016/j.ultrasmedbio.2006.12.007

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  18 in total

Review 1.  The smooth muscle cell in culture.

Authors:  J Chamley-Campbell; G R Campbell; R Ross
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

2.  Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi.

Authors:  Patricia A Schumann; Jonathan P Christiansen; Rachel M Quigley; Thomas P McCreery; Robert H Sweitzer; Evan C Unger; Jonathan R Lindner; Terry O Matsunaga
Journal:  Invest Radiol       Date:  2002-11       Impact factor: 6.016

Review 3.  Tissue factor and coronary artery disease.

Authors:  Arno H M Moons; Marcel Levi; Ron J G Peters
Journal:  Cardiovasc Res       Date:  2002-02-01       Impact factor: 10.787

4.  Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo.

Authors:  Michael S Hughes; Jon N Marsh; Hyuing Zhang; Adam K Woodson; John S Allen; Elizabeth K Lacy; Cordelia Carradine; Gregory M Lanza; Samuel A Wickline
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2006-09       Impact factor: 2.725

5.  Temperature dependence of ultrasonic enhancement with a site-targeted contrast agent.

Authors:  C S Hall; J N Marsh; M J Scott; P J Gaffney; S A Wickline; G M Lanza
Journal:  J Acoust Soc Am       Date:  2001-09       Impact factor: 1.840

6.  In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles.

Authors:  G M Lanza; D R Abendschein; C S Hall; M J Scott; D E Scherrer; A Houseman; J G Miller; S A Wickline
Journal:  J Am Soc Echocardiogr       Date:  2000-06       Impact factor: 5.251

7.  Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model.

Authors:  Jon N Marsh; Christopher S Hall; Michael J Scott; Ralph W Fuhrhop; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2002-01       Impact factor: 2.725

8.  Effect of endothelial cells and transforming growth factor-beta 1 on cultured vascular smooth muscle cell growth patterns.

Authors:  R J Powell; J L Cronenwett; M F Fillinger; R J Wagner
Journal:  J Vasc Surg       Date:  1994-11       Impact factor: 4.268

9.  Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins.

Authors:  Howard Leong-Poi; Jonathan Christiansen; Alexander L Klibanov; Sanjiv Kaul; Jonathan R Lindner
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

10.  Temperature dependence of acoustic impedance for specific fluorocarbon liquids.

Authors:  Jon N Marsh; Christopher S Hall; Samuel A Wickline; Gregory M Lanza
Journal:  J Acoust Soc Am       Date:  2002-12       Impact factor: 1.840

View more
  22 in total

1.  scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis.

Authors:  Christopher R Anderson; Joshua J Rychak; Marina Backer; Joseph Backer; Klaus Ley; Alexander L Klibanov
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

2.  Multifunctional microbubbles and nanobubbles for photoacoustic and ultrasound imaging.

Authors:  Chulhong Kim; Ruogu Qin; Jeff S Xu; Lihong V Wang; Ronald Xu
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

3.  In situ study of the impact of inter- and intra-reader variability on region of interest (ROI) analysis in preclinical molecular imaging.

Authors:  Frezghi Habte; Shradha Budhiraja; Shay Keren; Timothy C Doyle; Craig S Levin; David S Paik
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-03-08

Review 4.  Advances in molecular imaging with ultrasound.

Authors:  Ryan Gessner; Paul A Dayton
Journal:  Mol Imaging       Date:  2010-06       Impact factor: 4.488

Review 5.  Echographic imaging of tumoral cells through novel nanosystems for image diagnosis.

Authors:  Marco Di Paola; Fernanda Chiriacò; Giulia Soloperto; Francesco Conversano; Sergio Casciaro
Journal:  World J Radiol       Date:  2014-07-28

6.  Copper-64 Radiopharmaceuticals for Oncologic Imaging.

Authors:  Jason P Holland; Riccardo Ferdani; Carolyn J Anderson; Jason S Lewis
Journal:  PET Clin       Date:  2009-01

7.  Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.

Authors:  Ann-Marie Chacko; Elizabeth D Hood; Blaine J Zern; Vladimir R Muzykantov
Journal:  Curr Opin Colloid Interface Sci       Date:  2011-06       Impact factor: 6.448

Review 8.  Liquid perfluorocarbons as contrast agents for ultrasonography and (19)F-MRI.

Authors:  Raquel Díaz-López; Nicolas Tsapis; Elias Fattal
Journal:  Pharm Res       Date:  2009-11-10       Impact factor: 4.200

9.  Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.

Authors:  Carolyn J Anderson; Riccardo Ferdani
Journal:  Cancer Biother Radiopharm       Date:  2009-08       Impact factor: 3.099

10.  Programmable nanoparticle functionalization for in vivo targeting.

Authors:  Hua Pan; Jacob W Myerson; Lingzhi Hu; Jon N Marsh; Kirk Hou; Michael J Scott; John S Allen; Grace Hu; Susana San Roman; Gregory M Lanza; Robert D Schreiber; Paul H Schlesinger; Samuel A Wickline
Journal:  FASEB J       Date:  2012-10-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.